Torpedo Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $60K

  • Investors
  • 10

Torpedo Therapeutics General Information

Description

Developer of neuromodulation devices designed for the treatment of neurological disorders. The company's technology aims to increase the efficacy of deep brain stimulation by high-precision closed-loop deep brain stimulation devices, enabling neuroscientists and clinicians to study healthy brain function and potentially treat neurological diseases with greater precision and effectiveness.

Contact Information

Website
www.torpedotherapeutics.com
Formerly Known As
Neural Dynamics Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • BU Innovation Center
  • Mary Street, 8. Saint Mary Street
  • Boston, MA 02215
  • United States
+1 (617)
Primary Industry
Biotechnology
Vertical(s)
Nanotechnology, HealthTech, Life Sciences
Corporate Office
  • BU Innovation Center
  • Mary Street, 8. Saint Mary Street
  • Boston, MA 02215
  • United States
+1 (617)

Torpedo Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Torpedo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 03-Dec-2024 $60K Completed Product In Beta Test
6. Grant 01-Sep-2023 Completed Product In Beta Test
5. Accelerator/Incubator 01-Nov-2022 Completed Product In Beta Test
4. Grant 01-Sep-2022 Completed Product In Beta Test
3. Early Stage VC 05-May-2022 Completed Product In Beta Test
2. Grant 01-Sep-2021 $920K Completed Product In Beta Test
1. Grant 18-Sep-2018 $700K Completed Product In Beta Test
To view Torpedo Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Torpedo Therapeutics Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Torpedo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12239833-B2 Adaptive closed-loop dbs stimulation control Active 24-Feb-2023
US-20240285937-A1 Adaptive closed-loop dbs stimulation control Active 24-Feb-2023
EP-4669192-A2 Deep brain stimulation systems and methods Pending 24-Feb-2023
WO-2024178317-A2 Deep brain stimulation systems and methods Inactive 24-Feb-2023
WO-2024178317-A3 Deep brain stimulation systems and methods Inactive 24-Feb-2023 A61N1/0534
To view Torpedo Therapeutics’s complete patent history, request access »

Torpedo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Torpedo Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
SBXi Venture Capital Minority
Y Combinator Accelerator/Incubator Minority
Black Mountain Ventures Venture Capital Minority
Coho Deeptech Venture Capital Minority
GCAIA Capital Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Torpedo Therapeutics FAQs

  • When was Torpedo Therapeutics founded?

    Torpedo Therapeutics was founded in 2018.

  • Where is Torpedo Therapeutics headquartered?

    Torpedo Therapeutics is headquartered in Boston, MA.

  • What is the size of Torpedo Therapeutics?

    Torpedo Therapeutics has 3 total employees.

  • What industry is Torpedo Therapeutics in?

    Torpedo Therapeutics’s primary industry is Biotechnology.

  • Is Torpedo Therapeutics a private or public company?

    Torpedo Therapeutics is a Private company.

  • What is Torpedo Therapeutics’s current revenue?

    The current revenue for Torpedo Therapeutics is .

  • How much funding has Torpedo Therapeutics raised over time?

    Torpedo Therapeutics has raised $920K.

  • Who are Torpedo Therapeutics’s investors?

    SBXi, Y Combinator, Black Mountain Ventures, Coho Deeptech, and GCAIA Capital are 5 of 10 investors who have invested in Torpedo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process